CONTINUINGMEDICALEDUCATION INFORMATION
LearningObjectives
Upon completionof the activity, participants shouldbe able to:
1. Describe the changing landscapeof advancedprostate cancer
2. Evaluate theuseof imaging technologies in advanced castrate resistant prostate cancer
3. Assess the emerging roleof intermittent hormonal therapy in treating castration resistant advancedprostate
cancer
4. Define recent developments in prostate cancer treatment that affect and can impact patient quality-of-life
outcomes
TargetAudience
The activity is oriented to a targeted audience of physicians andmedical care professionals specializing in the
diagnosis and treatment of prostate cancer
CJPMedicalCommunicationsDisclosure
The employees ofCJPMedicalCommunicationshavenofinancial relationships todisclose.
TheCanadian Journal ofUrologyDisclosure
The employees of TheCanadian Journal ofUrologyhavenofinancial relationships todisclose.
AccreditationStatement
This activityhas beenplanned and implemented in accordancewith the accreditation requirements andpolicies
of theAccreditation Council for ContinuingMedical Education through the joint providership of theMedical
CollegeofWisconsin, TheCanadian Journal ofUrologyandCJPMedicalCommunications. TheMedicalCollege
ofWisconsin is accreditedby theACCME toprovide continuingmedical education for physicians.
AMACreditDesignationStatement
TheMedical College ofWisconsindesignates this journal-basedCME activity for amaximumof 16.0
AMAPRA
Category 1 Credits
™
. Physicians should claim only credit commensuratewith the extent of their participation in
this activity.
HoursofParticipation forAlliedHealthCareProfessionals
TheMedical College ofWisconsin designates this activity for up to 16.0 hours of participation for allied health
professionals.
Off-Label/InvestigationalUse
This educational activitymay containdiscussionof published and/or investigational uses of agents that arenot
indicatedby theUnitedStateFoodandDrugAdministration.Theopinionsexpressed in theeducationalactivityare
thoseof the facultyanddonotnecessarily represent theviewsof theMedicalCollegeofWisconsin,TheCanadian
Journal ofUrology, Carden JenningsPublishing, or the sponsors.
Beforeprescribinganymedication,physiciansshouldconsultprimaryreferencesand fullprescribing information.
Please refer to the official prescribing information for each product for discussion of approved indications,
contraindications, andwarnings. Further, participants should appraise the information presented critically and
are encouraged to consult appropriate resources for anyproduct ordevicementioned in thisprogram.
ReleaseDate:
April 7, 2014
ExpirationDate:
April 1, 2015
Time toCompleteActivity:
16.0hours
A5
©TheCanadian Journal ofUrology™: International Supplement, April 2014
